Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies
This study has been completed.
Study NCT00981721   Information provided by AstraZeneca

First Received on September 21, 2009.   Last Updated on June 17, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Solid Malignancies
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
cediranib (RECENTIN TM, AZD2171)
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services